Xenetic Biosciences, Inc. (XBIO): Price and Financial Metrics
XBIO Price/Volume Stats
| Current price | $4.10 | 52-week high | $5.20 |
| Prev. close | $4.09 | 52-week low | $2.78 |
| Day low | $3.81 | Volume | 36,500 |
| Day high | $4.65 | Avg. volume | 9,594 |
| 50-day MA | $3.93 | Dividend yield | N/A |
| 200-day MA | $3.95 | Market Cap | 5.35M |
XBIO Stock Price Chart Interactive Chart >
Xenetic Biosciences, Inc. (XBIO) Company Bio
Xenetic Biosciences, Inc. operates as a biopharmaceutical company. The Company focuses on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens, as well as offers cell-based therapeutics targeting the B-cell receptor on the surface of malignant tumor cells. Xenetic Biosciences serves patients in the United States.
XBIO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...